Impact of serum erythropoietin level on collateral vessel development in patients with coronary artery disease

Creative Commons License

ÖZYÜNCÜ N., GÜLEÇ H. S., ÖZDÖL Ç., CANDEMİR B., ONGUN A., TULUNAY KAYA C., ...More

ANATOLIAN JOURNAL OF CARDIOLOGY, vol.17, no.5, pp.386-391, 2017 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 17 Issue: 5
  • Publication Date: 2017
  • Doi Number: 10.14744/anatoljcardiol.2017.7419
  • Journal Name: ANATOLIAN JOURNAL OF CARDIOLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.386-391
  • Keywords: coronary collateral, erythropoietin, anemia, ELEVATION MYOCARDIAL-INFARCTION, ISCHEMIA-REPERFUSION INJURY, ENDOTHELIAL PROGENITOR-CELL, NITRIC-OXIDE, BLOOD-FLOW, OCCLUSION, NEOVASCULARIZATION, INTERVENTION, DETERMINANTS, ANGIOGENESIS
  • Ankara University Affiliated: Yes

Abstract

Objective: Experimental data have shown that Erythropoietin (EPO) stimulates angiogenesis and neovascularization which may result in improved collateral development. The aim of this study was to investigate the association between serum EPO levels and the extent of coronary collaterals. Patient characteristics possibly related with coronary collaterals were also sought.